Skip to main content
. 2023 Nov 17;9(6):e200113. doi: 10.1212/NXG.0000000000200113

Table 4.

Changes in Interpretation and Elimination of Secondary Findings for VUSs by Clinical MD Type

graphic file with name NXG-2023-000205t4.jpg

By variants
EDMD (N = 23) LGMD (N = 84) CMD (N = 50) DD (N = 22) Total (N = 179)
Change in genetic diagnosis, n (%)
 No 22 (95.7) 69 (82.1) 39 (78.0) 14 (63.6) 144 (80.4)
 Yes 1 (4.3) 15 (17.9) 11 (22.0) 8 (36.4) 35 (19.6)
Eliminated secondary finding, n (%)
 No 22 (95.7) 74 (88.1) 40 (80.0) 20 (90.9) 156 (87.2)
 Yes 1 (4.3) 10 (11.9) 10 (20.0) 2 (9.1) 23 (12.8)
By individuals
EDMD (N = 11) LGMD (N = 49) CMD (N = 29) DD (N = 8) Total (N = 97)
Change in genetic diagnosis, n (%)
 No 10 (90.9) 36 (73.5) 18 (62.1) 5 (62.5) 69 (71.1)
 Yes 1 (9.1) 13 (26.5) 11 (37.9) 3 (37.5) 28 (28.9)
Eliminated secondary finding, n (%)
 No 10 (90.9) 40 (81.6) 22 (75.9) 7 (87.5) 79 (81.4)
 Yes 1 (9.1) 9 (18.4) 7 (24.1) 1 (12.5) 18 (18.6)

Abbreviations: CMD = congenital muscular dystrophy; DD = distal muscular dystrophy; EDMD = Emery-Dreifuss muscular dystrophy; LGMD = limb-girdle muscular dystrophy.